Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Obstructive sleep apnea is a sleeping disorder where breathing is disturbed occasionally during sleep. It occurs when the throat muscles are shrink and block the air way when the person falls asleep. The patient with neurological disorders are more prone to obstructive sleep apnea. Snoring is the most remarkable sign of these disorder, excessive daytime sleepiness, non-refreshing sleep, chocking and snoring are the most common of obstructive sleep apnea.
The Asia Pacific obstructive sleep apnea market is witnessing tremendous growth during the forecast period of 2022-2028. The rising cases of undiagnosed patients is propelling growth of Asia Pacific obstructive sleep apnea market. The growing awareness in the therapeutic obstructive sleep apnea is also boosting growth of Asia Pacific obstructive sleep apnea market. However, patient discomfort by the use of mask during therapy is restraining growth of Asia Pacific obstructive sleep apnea market. Also, high cost of the sleep apnea devices is also hampering growth of Asia Pacific obstructive sleep apnea market.
The exclusive COVID-19 impact analysis report by axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the obstructive sleep apnea market. In addition, complete analysis of changes on the obstructive sleep apnea expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices.
_Market.jpg)
The Asia Pacific obstructive sleep apnea market is bifurcated into type, end user and country.
The Asia Pacific obstructive sleep apnea market is comprised of various type such as airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices. In which adaptive servo-ventilation is also contributing to the growth of Asia Pacific obstructive sleep apnea market. The rising adoption of sleep apnea devices is propelling growth of Asia Pacific obstructive sleep apnea devices. The growing number of undiagnosed patients is also boosting growth of Asia Pacific obstructive sleep apnea market.
The Asia Pacific obstructive sleep apnea market is comprised of end users such as hospitals and sleep laboratories and home care settings. In which home care settings is likely to dominate the market in 2020. The rising preference towards home health care is propelling growth of Asia Pacific obstructive sleep apnea market. The growing efforts for reduction of healthcare costs is also boosting growth of segment in Asia Pacific obstructive sleep apnea market.
The Asia Pacific obstructive sleep apnea market is studied for key countries such as China, India, Japan, Australia and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The developing healthcare infrastructure is propelling growth of Asia Pacific obstructive sleep apnea market. The growing research on sleep disorders is also boosting growth of Asia Pacific obstructive sleep apnea market.
The major key players of the markets are Becton Dickinson (CareFusion Corporation), BMC Medical Co. Ltd, Braebon Medical Corporation, Cadwell Laboratories Inc., Compumedics Limited, Curative Medical Inc, Fisher & Paykel Healthcare, GE Healthcare, ImThera, Invacare Corporation, Koninklijke Philips N.V., LivaNova, Nidek Medical India, Inspire Medical System, Somnomed, Oventus Medical and Drive Devilbiss Healthcare among others.
February 2021: The Cadwell acquired Sleepmate sleep diagnostic sensors from Ambu A/S. The Sleepmate products have been providing high quality and reliable sleep diagnostic sensor solutions for more than 30 years. Cadwell is now honoured to comprise Sleepmate portfolio as an integral part of its comprehensive sleep diagnostic solutions for both in-lab and at home testing.
August 2021: ResMed had launched their new positive airway pressure device in the US to help hundreds of millions of people with sleep apnea.
September 2020: ResMed launched first CPAP Nasal Mask with memory foam. The company recently launched their first continuos positive airway pressure (CPAP) nasal mask with a memory foam cushion, the AirTouch N20. As per the company it is the softest nasal mask till date.
October 2019: ResMed Launched AirFit N30 mask, a tube-down nasal cradle CPAP mask with a front tub which is a new option for sleep apnea treatment. ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, a nasal cradle cushion which sits under nasal bridge, eliminating soreness in those areas. The masks curved cushion is designed for supplying a secured seal regardless of how the wearer sleeps or moves.
The report analyses obstructive sleep apnea (OSA) market based on type, end user and country. By type, the market is segmented into the airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices. Based on end user, the market is bifurcated into homecare settings and hospital and sleep laboratories. The report also analyses the impact of COVID-19 on the market and it analysed that The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices. The report also comprised of major key players operating in the market.
Why to buy this report:
